Since both GATA1 and SET7 are overexpressed in breast cancer patients, and GATA1 and SET7 promote not only breast cancer cell growth but also tumor angiogenesis, inhibition of GATA1 and/or SET7 may be a useful strategy for breast cancer therapy. Here, GATA1 is linked to breast carcinoma.